FDA Warns of Xenical, Alli Liver Problems Following Worldwide Reports
The FDA is requiring new warnings about the risk of liver damage from Alli and Xenical after the two popular diet drugs have been linked to reports of death and liver failure.
The FDA issued an early communication last August indicating that they were investigating reports of Xenical and Alli liver damage. In a follow up drug safety communication issued Thursday, the agency indicates that at least 13 cases of severe liver injury from Alli and Xenical have been found, including at least two cases where patients died and three where a liver transplant was needed.
Xenical (orlistat 120mg) is a prescription medication that was approved by the FDA in 1999. The lower dose Alli (orlistat 60mg) is an over-the-counter weight-loss drug that was approved in 2007. Both drugs are marketed by GlaxoSmithKline, PLC, though Xenical is manufactured by Roche.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The medications are intended for use together with a reduced-calorie diet. They work by preventing the absorption of fats, thereby reducing caloric intake. In 2008, Xenical generated sales of $30 million and Alli generated sales of $131 million during its first full year on the market.
The new label changes will warn of rare cases of severe liver injury, and indicate that healthcare professionals and consumers should watch for symptoms of liver injury, including:
- Itching yellow eyes or skin
- Dark urine
- Light-colored stools
- Loss of appetite
Patients should stop using the drugs and contact their healthcare professional if these symptoms develop.
The FDA notes that an estimated 40 million individuals have used the medications, and only one of the reports of liver problems were found in the United States, involving a user of Alli. The remaining 12 cases occurred outside the United States, and involved liver problems with Xenical. There has been no direct causal relationship established between the two orlistat-based drugs and liver injury.
The primary known side effects of Alli and Xenical include oily and loose stools, fecal incontinence, frequent or urgent bowel movements and flatulence, which tend to be most severe when the treatment is started and may decrease with time.
There have been suggestions that orlistat could increase the risk of colon cancer and breast cancer, and the consumer advocacy group Public Citizen has called for an Xenical recall since 2006.
pamAugust 22, 2010 at 12:14 am
I am 38 yrs old and i have been on alli for 6 months and have changed my eating habits for the best and lost good amout of wieght slowly, how ever i ahve noticed a appetite decline! I am having burning in my upper area not to sure but i will go to Dr. this week make sure things are ok, my stools sometime are pale but other time i think normal, i am actually down to one capsule a day, i think it ha[Show More]I am 38 yrs old and i have been on alli for 6 months and have changed my eating habits for the best and lost good amout of wieght slowly, how ever i ahve noticed a appetite decline! I am having burning in my upper area not to sure but i will go to Dr. this week make sure things are ok, my stools sometime are pale but other time i think normal, i am actually down to one capsule a day, i think it has helped me chnge my diet for the best but am worried about this whole liver situation.
"*" indicates required fields
More Top Stories
Uber faces a lawsuit from four passengers who say they were sexually assaulted by drivers, due to the company's lack of security measures and focus on passenger safety.
A Bard PowerPort lawsuit claims the defective design of the port catheter led to a woman developing a severe infection and needing to have the implant surgically removed.
The new federal judge overseeing all talcum powder lawsuits has called for a Science Day to educate the court ahead of planned Daubert hearings which could decide if bellwether test trials can move forward.